Patents by Inventor Bo Lennart M. Friberg

Bo Lennart M. Friberg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7238713
    Abstract: Compounds and methods are provided for the treatment of disease conditions in which modification of cholinergic, especially muscarinic m1, m4, or both m1 and m4, receptor activity has a beneficial effect. In the method, an effective amount of a compound is administered to a patient in need of such treatment.
    Type: Grant
    Filed: July 17, 2003
    Date of Patent: July 3, 2007
    Assignee: Acadia Pharmaceuticals, Inc.
    Inventors: Carl-Magnus A. Anderson, Bo Lennart M. Friberg, Niels Skjaerbaek, Tracy A. Spalding, Allan K. Uldam
  • Patent number: 6627645
    Abstract: Compounds and methods are provided for the treatment of disease conditions in which modification of cholinergic, especially muscarinic m1, m4, or both m1 and m4, receptor activity has a beneficial effect. In the method, an effective amount of a compound is administered to a patient in need of such treatment.
    Type: Grant
    Filed: April 27, 2001
    Date of Patent: September 30, 2003
    Assignee: Acadia Pharmaceuticals, Inc.
    Inventors: Carl-Magnus A. Andersson, Bo Lennart M. Friberg, Niels Skjaerbaek, Tracy A. Spalding, Allan K. Uldam